Miami CTSI

News

Patients will be seen by UM clinicians and genetics experts, who will perform in-depth and comprehensive clinical examinations, as well as cutting-edge genomics investigations, including whole genome sequencing.

Miller School Becomes a Site for NIH’s Undiagnosed Diseases Network

09.24.2018

The University of Miami Miller School of Medicine is among five new academic medical sites across the nation that have joined the National Institutes of Health’s (NIH) Undiagnosed Diseases Network (UDN) and been awarded a grant by the agency to improve and accelerate the diagnosis of rare and undiagnosed conditions. The new awards, announced September 24, are part of the second phase of the agency’s expansion of the network.

CTSI Leadership and Central Operations Team: from left, top row, Patricia Avissar, Caprice Battle, Marisabel Davalos, Jonelle Wright, Ph.D., Sheela Dominguez and Stella Covelli; from left, bottom row, Rosalina Das, Raquel Perez, Dushyantha Jayaweera, M.D., Ralph L. Sacco, M.D., M.S., Daru Lane Ransford and Chin Chin Lee.

Major NIH Award Makes Miami CTSI a Hub for Biomedical Discovery and Innovation

08.24.2018

The Miami Clinical and Translational Science Institute has received a five-year $21.5 million National Institutes of Health grant, which will be supplemented by the Miller School of Medicine and the University of Miami Office of the Provost, to fund collaborative research to speed the discovery of new medical treatments and cures.

Summer Course Explores Commercial Potential of Research Discoveries

07.09.2018

Does your latest discovery have commercial value? Go beyond the lab and broaden the impact of your research project this summer by taking the National Institutes of Health’s I-Corps@NCATS Regional Short Course at the University of Miami Miller School of Medicine. The free, five-week course is designed specifically for teams of faculty, staff, postdoctoral associates, residents, students or entrepreneurs.

From left, keynote speaker Edward V. Nunes, M.D., with symposium co-organizer Viviana Horigian, M.D.

Medication-Assisted Treatment Can Lower Risk of Opioid Addiction Relapses

05.23.2018

Medication-assisted treatment may be the most effective strategy for preventing potentially fatal relapses for individuals recovering from opioid addictions, according to national experts at a University of Miami Miller School of Medicine symposium held May 21. “Medication strategies work for many people with opioid abuse disorder,” said Edward V. Nunes, M.D., professor of psychiatry at the Columbia University Medical Center.